This is a Validated Antibody Database (VAD) review about mouse Csnk2a2, based on 8 published articles (read how Labome selects the articles), using Csnk2a2 antibody in all methods. It is aimed to help Labome visitors find the most suited Csnk2a2 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Csnk2a2 synonym: 1110035J23Rik; C77789; CK2; casein kinase II subunit alpha'; CK II alpha'; casein kinase II, alpha 2, polypeptide

Bethyl
rabbit polyclonal
  • western blot; human; fig 6
Bethyl Csnk2a2 antibody (Bethyl Laboratories, A300-199A) was used in western blot on human samples (fig 6). Sci Rep (2016) ncbi
rabbit polyclonal
  • western blot; human; fig 1
Bethyl Csnk2a2 antibody (Bethyl, A300-199A) was used in western blot on human samples (fig 1). Nucleic Acids Res (2015) ncbi
rabbit polyclonal
  • western blot; human
Bethyl Csnk2a2 antibody (Bethyl Laboratories, A300-199A) was used in western blot on human samples . Mol Cell Pharmacol (2014) ncbi
rabbit polyclonal
  • western blot; human; fig 1
Bethyl Csnk2a2 antibody (Bethyl Laboratories, A300-199A) was used in western blot on human samples (fig 1). Breast Cancer Res (2015) ncbi
rabbit polyclonal
  • western blot; human; 1:2500
In order to study HCV assembly using genotype 1a H77S, Bethyl Csnk2a2 antibody (Bethyl Laboratories, A300-199A) was used in western blot on human samples at 1:2500. PLoS ONE (2014) ncbi
rabbit polyclonal
  • western blot; human
In order to use tenfibgen-shell nanocapsule technology for tumor-directed delivery of single stranded DNA/RNA chimeric oligomers in vivo, Bethyl Csnk2a2 antibody (Bethyl, A300-199A) was used in western blot on human samples . PLoS ONE (2014) ncbi
Santa Cruz Biotechnology
mouse monoclonal (31)
  • western blot; mouse
Santa Cruz Biotechnology Csnk2a2 antibody (Santa Cruz Biotechnology, SC-136281) was used in western blot on mouse samples . Oncogene (2015) ncbi
Abcam
rabbit polyclonal
  • immunocytochemistry; human
Abcam Csnk2a2 antibody (Abcam, ab10474) was used in immunocytochemistry on human samples . Arch Biochem Biophys (2014) ncbi
Articles Reviewed
  1. Afsar T, Trembley J, Salomon C, Razak S, Khan M, Ahmed K. Growth inhibition and apoptosis in cancer cells induced by polyphenolic compounds of Acacia hydaspica: Involvement of multiple signal transduction pathways. Sci Rep. 2016;6:23077 pubmed publisher
  2. Peng B, Wang J, Hu Y, Zhao H, Hou W, Zhao H, et al. Modulation of LSD1 phosphorylation by CK2/WIP1 regulates RNF168-dependent 53BP1 recruitment in response to DNA damage. Nucleic Acids Res. 2015;43:5936-47 pubmed publisher
  3. Trembley J, Unger G, Gomez O, Abedin J, Korman V, Vogel R, et al. Tenfibgen-DMAT Nanocapsule Delivers CK2 Inhibitor DMAT to Prostate Cancer Xenograft Tumors Causing Inhibition of Cell Proliferation. Mol Cell Pharmacol. 2014;6:15-25 pubmed
  4. Kren B, Unger G, Abedin M, Vogel R, Henzler C, Ahmed K, et al. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy. Breast Cancer Res. 2015;17:19 pubmed publisher
  5. Golden D, Cantley L. Casein kinase 2 prevents mesenchymal transformation by maintaining Foxc2 in the cytoplasm. Oncogene. 2015;34:4702-12 pubmed publisher
  6. Kim S, Jin B, Choi S, Han K, Ahn S. Casein kinase II inhibitor enhances production of infectious genotype 1a hepatitis C virus (H77S). PLoS ONE. 2014;9:e113938 pubmed publisher
  7. Trembley J, Unger G, Korman V, Abedin M, Nacusi L, Vogel R, et al. Tenfibgen ligand nanoencapsulation delivers bi-functional anti-CK2 RNAi oligomer to key sites for prostate cancer targeting using human xenograft tumors in mice. PLoS ONE. 2014;9:e109970 pubmed publisher
  8. Salvi M, Raiborg C, Hanson P, Campsteijn C, Stenmark H, Pinna L. CK2 involvement in ESCRT-III complex phosphorylation. Arch Biochem Biophys. 2014;545:83-91 pubmed publisher